ORLANDO — Rusfertide, a weekly self-injected peptide, maintained control of hematocrit levels and reductions in phlebotomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback